Public-registry site landscape for NCT06409663, a Severe Acute Respiratory Syndrome Coronavirus 2 Infection study sponsored by Novavax. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT06409663 (registry record) |
| Sponsor | Novavax |
| Condition(s) | Severe Acute Respiratory Syndrome Coronavirus 2 Infection |
| Phase | PHASE3 |
| Listed sites | 2 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT06409663 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →